Backgrounds: With the aim to validate the applicability of the eighth T classifications of AJCC/ UICC staging system for nasopharyngeal carcinoma patients Materials and methods: We compare the seventh and eighth T classifications of the UICC/AJCC staging system in 382 newly diagnosed nasopharyngeal carcinoma patients without cervical lymph node metastasis who were staged with magnetic resonance imaging and treated by intensity-modulated radiotherapy. Univariate analysis was performed using the log-rank test and multivariate analyses with the Cox proportional hazards model were used to evaluate the prognostic values between adjacent stage categories. The Akaike information criterion and Harrell's concordance index were applied to compare the two systems. Results: The median follow-up time was 61.1 months. For local relapse-free survival and distant metastasis failure-free survival, the eighth editions had superior prognostic value to the seventh edition. The Akaike information criterion value was smaller and Harrell's concordance index value was larger for the eighth edition compared with the seventh edition staging system. Our research also found that the difference in overall survival, local relapse-free survival and distant metastasis failure-free survival rates between T1 and T2 patients was not significant according to the eighth edition of the UICC/AJCC staging system, indicating that the discrimination among T1-2 patients was diminished. Conclusions: Intensity-modulated radiotherapy with elective neck irradiation provides excellent local-regional control for nasopharyngeal carcinoma patients and the eighth T classification seems to be superior to the seventh T classification. Since local control has improved in the modern era, the study considered that the staging system could be further improved and simplified by downstaging the current T2 classification patients to T1 with modern treatment. Researchers are attempting to incorporate individualized prognostic factors, such as Epstein-Barr virus DNA, into nomogram.
Introduction
Nasopharyngeal cancer (NPC) is the most common head-and-neck malignancy in Southeast Asia, and it is highly sensitive to radiotherapy (RT) or chemotherapy. The incidence of NPC is approximately 30-80 per 100 000 (1) in Southern China. Early stage NPC patients are usually treated with RT alone, and chemoradiotherapy is the standard treatment modality for locoregionally advanced disease.
Nasopharynx has a rich lymphatic network, and the cervical lymph node metastasis in patients with nasopharyngeal carcinoma (NPC) occurs early. In particular, the retropharyngeal space and the level II region are most affected. A large number of studies have shown that cervical lymph node metastases of nasopharyngeal follow a predictable pattern: the transfer rate from region II to III and IV is gradually reduced, and skip metastases in the neck regions are relatively rare. Irradiation to the bilateral cervical nodal areas down to the supraclavicular fossa has been the standard practice for radiation therapy of NPC, including patients presenting with N0 disease. In addition, high-dose irradiation to the neck area is associated with side effects, such as soft tissue fibrosis, which may adversely affect patients' quality of life. The main reasons for failure in patients with N0 NPC are nasopharyngeal recurrence and distant metastases; neck recurrence alone had no obvious effect on survival rate. Therefore, to improve the patients' quality of life, elective levels II, III, and VA irradiation are suitable for NPC without neck lymph node metastasis (2) (3) (4) .
The accurate prediction of the failure pattern and the survival outcome is crucial for patient management. The TNM stage is currently the most important known prognostic factor. In addition to meeting the demand for accurate prognostication, the ideal staging system must also be globally applicable. The Union for International Cancer Control (UICC) has been making concerted efforts to continually improve the TNM staging system in line with evolving investigation and treatment methods. The recent seventh edition staging system for NPC, which is based on the sixth edition, is now universally accepted. The eighth edition of the AJCC/UICC staging system will soon be introduced; international multidisciplinary experts are involved in the preparatory process. The system is based on an extensive literature review and among the suggestions reported in the literature. Three issues related to the classification criteria of T category demand serious consideration: (i) the controversy about the significance of the masticator space (MS) and the uncertainty about the significance of prevertebral muscle invasion. Based on a series of studies of 1609 patients staged with magnetic resonance imaging (MRI) and irradiated with intensity-modulated radiotherapy (IMRT) at two hospitals (one in Hong Kong and another in Fujian in mainland China), it was recommended that the eighth T classification include changing the criterion of medial pterygoid (MP)/lateral pterygoid (LP) involvement without other T3/T4 criteria from T4 to T2, and adding prevertebral muscle involvement as a T2 criterion (Table 1) (5, 6) . Other adjustments include T0 is added for Epstein-Barr virus (EBV)-positive unknown primary with cervical lymph node involvement.
As IMRT has gradually replaced two-dimensional conventional RT as the first-line RT technique; it is imperative to revaluate the scope and dose of the preventive exposure of the neck in patients with N0 NPC (7) . With the aim to validate the applicability of the eighth edition of AJCC/UICC staging system for NPC patients, we compare the seventh and eighth T classifications of the UICC/AJCC staging system in NPC patients without cervical lymph node metastasis who were staged with MRI and treated by IMRT.
Materials and methods

Patient and pretreatment evaluations
Between January 2009 and December 2011, data from 1732 consecutive and non-selected histologically proven NPC patients were collected at Fudan University Shanghai Cancer Center, and 382 patients were found no clinical evidence of neck node metastasis. All patients received elective neck irradiation to levels II, III, VA.
Pretreatment evaluation consisted of a complete history and physical examination, indirect or fibre optic endoscopic examination, complete blood counts, determination of serum electrolytes, chest CT scan or X-ray, MRI scan of the head and neck, ultrasound of the liver and abdomen, and dental evaluation. Urinalysis, bone scan and PET-CT were performed when clinically indicated.
All MRI scans were revaluated separately by two radiologists specializing in head-and-neck carcinomas. If a consensus could not be reached, the research team then defined the stage according to the staging system and other information, such as cranial nerve palsy in T4 disease. The clinical records and MRI results of all patients were collected into a database to be restaged accurately according to the criteria of the eighth and seventh T classifications of the UICC/AJCC staging system.
Intensity-modulated radiotherapy
Immobilization and simulation All patients were immobilized in the supine position with a thermoplastic mask. CT was performed after immobilization, obtaining 3-mm slices from the anterior clinoid process to the hyoid bone and 5-mm slices from the hyoid bone to 2 cm below the sternoclavicular joint. The CT data were imported to treatment planning system (TPS) for treatment design (8) .
Target delineation
The target volumes were defined according to the definitions of the ICRU50 and 62 (International Commission on Radiation Units and Measurements). All received elective neck irradiation to levels II, III and VA, and one clinical target volume (CTV) was defined in our RT: CTV1. The CTV1 was defined as the high-risk region that included GTV_P plus a 5-to 10-mm margin. CTV1 should also encompass the entire nasopharynx, parapharyngeal space, clivus, base of skull, pterygoid fossa, posterior half of ethmoidal sinus, inferior sphenoid sinus and posterior edge of nasal cavity and maxillary sinuses. If the tumour involved the inferior sphenoid sinus, the whole sphenoid sinus should be encompassed. The high-risk CTV should include bilateral coverage of levels II, III, VA and RLNs in all these patients (9) .
Treatment planning and delivery
Inverse IMRT plans were optimized using Pinnacle TPS. The prescribed dose was 66 Gy in 30 fractions to PTV_G for T1-2 and 70.4 Gy in 32 fractions for T3-4. The dose delivered to PTV_C for subclinical disease and regional lymphatics was 60 Gy at high risk in 30-32 fractions. All patients were treated with one fraction per day for 5 days per week. The normal tissue constraints and plan evaluation were in accordance with the Radiation Therapy Oncology Group 0225 protocol.
Chemotherapy
All stage I-IIA patients were treated with radiation alone. Cisplatinbased chemotherapy was recommended to medically fit patients with stage IIB-IVB disease. At that time, our institution was conducting a clinical trial comparing the efficacy and toxicities of induction chemotherapy and CCRT with induction chemotherapy and adjuvant chemotherapy. Thus, these two modalities accounted for most.
There were several regimens of induction chemotherapy and adjuvant chemotherapy in our institution, including PF, TPF and GP. The 
Patient evaluation
Patients were evaluated weekly during radiation therapy. After treatment completion, follow-up assessments were conducted every 3 months for the first 2 years, every 6 months from the 3rd to 5th year, and annually thereafter. Each follow-up included medical history, physical examination and nasopharyngoscopy. An enhanced MRI of the nasopharynx and neck areas was performed every 6-12 months after treatment. Chest X-ray and abdominal ultrasonography were conducted once yearly. Additional tests were ordered whenever there was any clinical indication. Adverse events related to chemotherapy and RT were graded by the National Cancer Institute Common Toxicity Criteria, version 3.0 and by the Radiation Therapy Oncology Group criteria, respectively. The assessment of tumour response was based on MRI findings according to the Response Evaluation Criteria for Solid Tumors criteria.
Statistical analysis
The follow-up time was calculated from the day of the completion of IMRT. The Statistical Package for Social Sciences (SPSS version 22.0) software was used for statistical analysis. The Kaplan-Meier method was used to evaluate the overall survival (OS), local relapsefree survival (LRFS), regional relapse-free survival (RRFS), distant metastasis failure-free survival (DMFS) and disease-free survival (DFS). Univariate analysis was performed using the log-rank test.
Multivariate analyses with the Cox proportional hazards model were used to test the independent significance of the predictors, and two-tailed P values <0.05 were considered statistically significant. The Akaike information criterions (AICs), as well as Harrell's concordance index (C-index), were applied to the Cox proportional hazard regression model to correct for the potential bias in comparing prognostic systems with different numbers of stages. AIC was defined as follows: AIC = −2 log maximum likelihood + 2 × (the number of parameters in the model). A smaller AIC value indicated a better model for predicting the outcome. C-index was performed using R software (version 3.2.4), and larger C-index values indicated a better model for predicting the outcome (6,10,11). Table 2 .
Results
Patient characteristics
Failure patterns
The median follow-up time was 61.1 months, with a range from 1 to 91 months. At the end of the follow-up period, 39 patients were diedincluding two patients died due to massive nasopharyngeal haemorrhage, 2 patient died due to myocardial infarction. The 5-year OS, LRFS, RRFS, DMFS and DFS were 86.9, 96.7, 99.1, 93.3 and 82.6%, respectively. At the time of this analysis, a total of 12 (3.1%) patients developed local recurrence in the primary area, 3 (0.8%) patients experienced neck recurrence and 23 (6.0%) patients developed distant metastasis (Table 3) .
Univariate analysis
The value of various potential prognostic factors, including gender, age, T classification, use of chemotherapy and use of boost on predicting OS, LRFS, RRFS, DMFS and DFS, was evaluated (Table 4) . Univariate analysis showed that the 5-year OS and DFS were found to be significant both by the seventh and the eighth T classifications. For LRFS and DMFS, the eighth T classification had superior prognostic value to the AJCC/UICC seventh T classification (P = 0.032 vs. P = 0.086 and P = 0.006 vs. P = 0.063, respectively). RRFS was not affected by any studied prognostic factor, including age, gender, T classification, chemotherapy and radiation boost, because the number of regional failures was too small to allow for meaningful analysis. Age was a significant prognostic factor for OS (P = 0.004) and DFS (P = 0.008). Gender was a significant prognostic factor for DMFS (P = 0.044).
The 5-year OS for T1-4 classifications patients were 92.4, 92.0, 87.3 and 76.5%, respectively, according to the seventh edition staging system. A higher T category was associated with poorer OS. As shown in Fig. 1 , the differences between T1 and T4 classifications and between T2 and T4 classifications were found to be significant (P = 0.001 and P = 0.000), and the differences between T1 and T3 classifications and between T2 and T3 classifications were found to be significant (P = 0.042 and P = 0.041) based on the eighth edition staging system. However, there were no significant differences between T1 and T3 classifications (P = 0.204) and between T2 and T3 classifications (P = 0.215) based on the seventh edition. The same results were found in LRFS, DMFS and DFS. Although the eighth edition establishes a better distinction between adjacent T classificationsfor OS, LRFS, DMFS and DFS, there are some shortcomings. In both editions, the curves for T1 and T2 classifications almost overlapped, without significant differences. Thus, this study considered that with modern treatment, the staging system could be further improved and simplified by downstaging the current T2 classification to T1 classification.
Multivariate analysis
Since both the seventh T classification and the eighth T classification were prognostic factors in the univariate analysis for DFS and OS, two separate multivariate models were performed: one including age, chemotherapy and the seventh T classification, and the other including age, chemotherapy and the eighth T classification. As shown in Table 5 , in the model based on the seventh T classification, age (hazard ratio, HR = 1.875), chemotherapy (HR = 0.462) and the seventh T classification (HR = 2.081) were independent prognostic parameters for DFS. Similarly, in the model based on the eighth T classification, age (HR = 1.829), chemotherapy (HR = 0.360) and the eighth T classification (HR = 2.351) were independent prognostic parameters for DFS. Then, the performance of the seventh and the eighth systems were quantified by the AIC value. The AIC value was smaller for the eighth edition (692.16) compared with the seventh edition staging system (695.27), which indicates that the eighth T classification has a better prognostic stratification. An analysis of the C-index for the two models showed that he value for the eighth T classification (0.6593) was larger than the seventh T classification (0.6508). Thus, it is not surprising that the eighth T classification had smaller AIC and higher C-index values for all end points compared with the seventh T classification, indicating that it is more informative about a patient's outcome.
Discussion
There is little controversy that IMRT is the treatment of choice for NPC, as dosimetric studies have demonstrated the clear advantages of IMRT in terms of improving the dose conformity for complex tumour targets and better protecting the adjacent organs at risk (1) . The TNM staging system is crucial for predicting prognosis, guiding treatment strategy for different risk groups and facilitating the exchange of information between oncology centres. The seventh staging system was revised mainly based on the data from the twodimensional conventional RT era, and a variety of studies have reported that the survival rates between each T classification in NPC patients are not significantly different after treatment with IMRT (12) . Based on extensive analyses and evidence from a retrospective study of 1609 patients with a median follow-up of 5 years, all staged with MRI and irradiated with IMRT at two major centres in Hong Kong and mainland China, Pan et al. (5) made proposals to inform the eighth edition of the TNM classification of NPC with the intent to improve the NPC staging system, allow for more accurate prediction of prognosis and better guide NPC treatment options. The prevertebral space, which is located directly anterior to cervical spine and behind the retropharyngeal space, is a high risk site for tumour involvement (13) . Oropharynx, hypopharynx and NPC, which arise from the posterior pharyngeal mucosal wall, may infiltrate the prevertebral space (14, 15) . Involvement of prevertebral space in oropharyngeal or hypopharyngeal cancer is regarded as the most advanced T stage disease (T4b) according to the seventh edition of the UICC/AJCC staging system due to difficulty of resecting a tumour from the longus colli/capitis muscle, which is usually associated with poor long-term survival (16) . However, being a nonsurgical treatment disease, NPC patients had excellent local-regional control and long-term survival with prevertebral space involvement if they are treated with curative RT, especially IMRT. Zhang et al. (17) analysed the data of 1504 NPC patients with parapharyngeal extension by MRI. With 110 months of follow-up, they found that OS, LRFS and DMFS with mild parapharyngeal extension (MP muscle of MS, or carotid, prestyloid, and prevertebral or retropharyngeal space) were significantly higher than in those T3 disease (all P ≤ 0.015), and they found that parapharyngeal extension should be subclassifed and mild parapharyngeal extension should be classified as T2 classification disease.
As defined with anatomical criteria, the MS is a deep fascial space outlined by a superficial layer of the deep cervical fascia which is located in the anterior-lateral side of the parapharyngeal space and contains the masticatory muscles, posterior mandible and mandibular nerve (18) . In the definition widely adopted in diagnostic radiology, the four masticatory muscles include the MP, the LP, the temporalis muscles and masseter muscles. According to the seventh edition of UICC/AJCC staging system, MS involvement, including all four masticatory muscles, was classified as T4, which was consistent with the definition adopted in diagnostic radiology. Nonetheless, tumours with involvement of MP ± LP were all upstaged to T4 disease have impact on the overall group staging, estimation of prognosis and management strategy, especially the use of chemoradiotherapy. Sze et al. (19) analysed the data of 1104 NPC patients using modern RT techniques with either 3DCRT or IMRT and restaged according to the seventh edition of AJCC staging system; tumours with MP and/or LP involvement but did not fulfil the criteria for T3 or T4 were staged as TX. With 7 years of follow-up, they found that patients with TX disease had similar survival rates as with T1-T2 and had a significantly better 5-year OS rate (86.6% vs. 76.6%; P = 0.013) and a trend of higher 5-year DMFS rate (91.5% vs. 81.3%; P = 0.09) than patients with T3 disease. They have demonstrated that NPC with extension to the MP and/or LP alone without fulfilling the other criteria for T3 and T4 should be staged as T2 disease. The similar results were found by Chen et al. (20) .
However, Pan et al. (5) reported that after they staged the patients according to the eighth edition of the UICC/AJCC staging system, they found that the OS and DMFS curves between T1 and T2 (P = 0.19, P = 0.16) did not significantly differ. Our research also found that the difference in OS, LRFS and DMFS rates between T1 and T2 patients was not significant according to the eighth edition of the UICC/AJCC staging system, indicating that the discrimination among T1-2 patients was diminished. Since local control has improved in the modern era, the eighth T classification remains controversial and the proposal of down stage T2 to T1 seemed to be reasonable. Clinical outcomes including local control rate and distant metastasis in patients who were treated with total dose less than 60 Gy would be different compared with those who were treated with definitive IMRT using a total dose of 66 Gy or more. In our study, 1 patient failed to complete RT due to Grade 3 mucositis and odynophagia.
In the eighth edition of the UICC/AJCC staging system, T0 classification is added for EBV positive unknown primary with cervical lymph node involvement. However, for T1-4 classifications, the eighth edition of the UICC/AJCC staging system only incorporates parameters describing the on the anatomic extension of the primary tumour diagnosed by imaging methods, pathologic and histologic features and clinical symptoms. Sun et al. (21) reported that EBV serological biomarkers may enhance the accuracy of TNM staging and help to avoid excessive imaging examinations in routine evaluation. The similar results were found by Sun et al. (22) . Nonetheless, as EBV DNA is not routinely available in most of the hospitals and no consensus on measuring or defining its reference value to bring these new molecular factors into the staging system and address the collinearity between EBV DNA and T classification presents a most challenging task.
There were several limitations of this study. First, this is a retrospective study in a single centre. The retrospective nature of this analysis certainly constitutes pitfall of this study, although a relatively large number of contiguous and non-selected patients were included. Longer follow-up and a larger sample of uniform treatment are needed for assessing the locoregional control and feasibility of elective neck irradiation, to allow for a clearer distinction between the two models.
Conclusions
IMRT with elective neck irradiation provides excellent local-regional control for NPC patients without cervical lymph node metastasis and the eighth T classification seems to be superior to the seventh T classification. Because patients with T2 disease had similar treatment outcome to T1 classification patients, this study considered that with modern treatment, the staging system could be further improved and simplified by downstaging the current T2 classification patients to T1. Researchers are attempting to incorporate individualized prognostic factors, such as EBV DNA, into nomogram. CI, confidence interval; HR, hazard ratio; AIC, Akaike information criterion; C-index, Harrell's concordance index; P values were calculated using an adjusted Cox proportional hazards model.
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